181

Shroom compound psilocybin shows promise for bipolar disorder in early trial (www.livescience.com)

submitted 11 months ago by DannyMac@lemmy.world to c/science@lemmy.world

10 comments fedilink hide all child comments

top 10 comments

sorted by: hot top controversial new old

[-] IDontHavePantsOn@lemm.ee 26 points 11 months ago

Basically every time a psilocybin study is conducted for use in mental health applications it's found to be beneficial. It's just that the DEA doesn't give a fuck and refuse to change the schedule of the drug even with countless studies showing it's effectiveness, as well as countless doctors, researchers, and institutes recommending they reduce psilocybin to schedule III.

Also, we all know what they were doing with that thumbnail.

[-] Cylusthevirus@kbin.social 9 points 11 months ago

I'm feeling stupid this morning, what were they doing with the thumbnail?

[-] Corkyskog@sh.itjust.works 5 points 11 months ago

? Not sure what the color filter is called, but it's an upside down mushroom.

[-] IDontHavePantsOn@lemm.ee 4 points 11 months ago

I guess it depends on what view and what app your using, but on my phone with a small thumbnail in list view it looks like a butthole.

[-] threeduck@aussie.zone 3 points 11 months ago

Looks like a sharpie in the pooper

[-] rustydrd@sh.itjust.works 3 points 11 months ago

I think the issue is a bit more than the DEA not wanting to move, and it's also related to how many studies showing positive effects of psychedelics have severe methodological or other important issues. This podcast summarizes some of those issues very nicely in case anyone's interested: https://www.thestudiesshowpod.com/p/episode-4-psychedelics

[-] IDontHavePantsOn@lemm.ee 3 points 11 months ago

I'll listen to the podcast because I'm sure there's info in it that will be new to me, but I do know drug scheduling creates a purgatory that makes substances difficult to research. When the scheduling means that it can't be produced in amounts to create meaningful clinical studies, the "drugs with no currently accepted medical use" definition is difficult to get out of.

To add on to that, if John Hopkins research labs, the same one that came up with CPR, water purification, and genetic engineering, thinks psilocybin has medical use and merit, I believe them.

[-] Addv4@kbin.social 21 points 11 months ago

While I'm all for descheduling psilocybin (and decriminalizing it as well), it should be noted that this was a very small sample size study (15 people) and I've heard anecdotal warnings to not take shrooms if bipolar or schizophrenic for years, as there might be a slight risk of psychosis.

[-] fubbernuckin@lemmy.world 18 points 11 months ago

You also have to take into account the setting the test was administered in. The participants underwent therapy before, during, and after the treatment. Being in a safe space with immediate access to mental health professionals probably decreases the risks substantially.